Yibing Lu
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Diabetes Treatment and Management
- Thyroid Cancer Diagnosis and Treatment
Papers in
-
- Metabolism, Diabetes, and Cancer 7
-
- Diabetes Treatment and Management 7
- Diabetes Management and Research 4
- Thyroid Cancer Diagnosis and Treatment 3
- Co-authors
- Dafa Ding (12 shared papers)Xiaolong Ye (6 shared papers)Heng Miao (5 shared papers)Jiarong Xu (4 shared papers)You Na (4 shared papers)Qun Zhu (3 shared papers)Qiang You (4 shared papers)Shanshan Huang (3 shared papers)
- Journals
- Diabetes Obesity and Metabolism (5 papers)Oncology Reports (2 papers)JAMA (1 paper)American Journal of Nephrology (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Yibing Lu
33 papers receiving 745 citations
Yibing Lu's Hit Papers
Peers
Comparison fields: 5 of 88
- Geriatrics and Gerontology 67
- Endocrinology, Diabetes and Metabolism 189
- Cancer Research 168
- Nephrology 70
- Physiology 37
Countries citing papers authored by Yibing Lu
This map shows the geographic impact of Yibing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibing Lu more than expected).
Fields of papers citing papers by Yibing Lu
This network shows the impact of papers produced by Yibing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibing Lu. The network helps show where Yibing Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yibing Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 92 | |
| 2 | 2017 | 92 | |
| 3 | 2015 | 86 | |
| 4 | Tirzepatide for Weight Reduction in Chinese Adults With Obesity Hit paper breakdown → | 2024 | 50 |
| 5 | 2018 | 41 | |
| 6 | 2018 | 40 | |
| 7 | 2020 | 36 | |
| 8 | 2012 | 33 | |
| 9 | 2016 | 31 | |
| 10 | 2018 | 31 | |
| 11 | 2013 | 29 | |
| 12 | MicroRNA-134-5p promotes high glucose-induced podocyte apoptosis by targeting bcl-2. | 2018 | 24 |
| 13 | 2019 | 19 | |
| 14 | 2018 | 19 | |
| 15 | 2022 | 17 | |
| 16 | 2021 | 15 | |
| 17 | 2020 | 14 | |
| 18 | 2016 | 13 | |
| 19 | 2023 | 13 | |
| 20 | 2020 | 12 |
About Yibing Lu
Yibing Lu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Cancer Research, Epidemiology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 756 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (7 papers), Cancer-related molecular mechanisms research (6 papers), Diabetes Management and Research (4 papers), Autophagy in Disease and Therapy (3 papers), MicroRNA in disease regulation (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Geriatrics and Gerontology (67 citations), Endocrinology, Diabetes and Metabolism (189 citations), Cancer Research (168 citations), Nephrology (70 citations) and Physiology (37 citations). Yibing Lu has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Dafa Ding, Xiaolong Ye, Heng Miao, Jiarong Xu, You Na, Qun Zhu, Qiang You, Shanshan Huang, Bin Song and Chao Liu. Their work appears in journals such as Diabetes Obesity and Metabolism, Oncology Reports, JAMA, American Journal of Nephrology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.